Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-15 Sale |
2022-12-19 4:45 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
445 | $10.9 | $4,851 | 10,753 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 6:36 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
8,600 | $13.01 | $111,886 | 11,198 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 5:04 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
2,300 | $17.2 | $39,560 | 11,198 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-12-19 Option Award |
2022-12-21 4:36 pm |
2023-12-19 2032-12-19 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
14,400 | $0 | 25,153 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 6:36 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
8,600 | $1.42 | 11,198 (Direct) |
View |
| 2022-12-01 Exercise |
2022-12-02 6:36 pm |
2014-01-01 2023-01-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
8,600 | $0 | 11,198 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 5:04 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
2,300 | $4.73 | 11,198 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 5:04 pm |
2013-03-01 2022-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
2,300 | $0 | 11,198 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:16 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
17,550 | $0 | 22,898 (Direct) |
View |
| 2021-03-18 Exercise |
2021-03-22 4:19 pm |
2012-03-21 2021-03-21 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
4,500 | $0 | 5,348 (Direct) |
View |
| 2021-03-18 Exercise |
2021-03-22 4:19 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
4,500 | $3.51 | 5,348 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:41 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 4:24 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO |
5,000 | $0 | 5,000 (Direct) |
View |